Industry News
MD Anderson studies skin cancer patients resistant to leading therapy
2/26/2015
Powerful drugs known as BRAF-inhibitors have been crucial for melanoma patients, saving lives through their ability to turn off the BRAF protein's power to spur cancer cell growth.
Scientists find cancer weak spots for new targeted drugs
2/26/2015
Scientists have identified weak spots in cancer cells that could be targeted and attacked by new precision drugs.
Filipino newcomers to Canada diagnosed with breast cancer at a younger age
2/26/2015
They are also more likely to be diagnosed with a more aggressive form of cancer and are more likely to undergo a mastectomyFilipinos who move to Canada are diagnosed with breast cancer at a...
Mapping lizard venom makes it possible to develop new drugs
2/26/2015
Venom and lizardsGila and beaded lizards are the classic venomous lizards. However, it was recently shown that venom is also used by a number of other species, such as the awesome Komodo monitors...
Previously unknown effect of vitamin A identified
2/26/2015
The signal molecule, retinoic acid, is a product of vitamin A which helps to instruct how different types of tissue are to be formed in the growing embryo.
Castle Biosciences announces publication of esophageal cancer study
2/25/2015
Castle Biosciences, Inc. has announced the publication of the second clinical validation study of its multi-analyte test for esophageal cancer.
Clarithromycin as an anti-cancer agent
2/25/2015
An antibiotic may join the ranks of drugs suitable for repurposing as anti-cancer treatments, according to new research from the Repurposing Drugs in Oncology (ReDO) project published in...
Returning to work can help cancer patients with their recovery from bone marrow (or stem cell) transplants, a new report by the blood cancer charity Anthony Nolan has revealed.
Open access to large cancer datasets is critical to clinical advances
2/25/2015
A major challenge facing cancer researchers is the identification and treatment of drug resistant cancers.
Working with cells taken from children with a very rare but ferocious form of brain cancer, Johns Hopkins Kimmel Cancer Center scientists have identified a genetic pathway that acts as a master...